DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Niesvizky R, Martin III TG, Bensinger WI. et al.
Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.
Clin Cancer Res 2013;
19 (08) 2248-2256
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.